Clinical Trials Directory

Trials / Sponsors / Rivus Pharmaceuticals, Inc.

Rivus Pharmaceuticals, Inc.

Industry · 11 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With
MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 22026-02-13
CompletedPhase 1, Open-Label, Randomized, Study of the Safety and Pharmacokinetics of HU6
Overweight
Phase 12025-10-13
CompletedRelative Bioavailability Study of HU6
Healthy
Phase 12024-07-24
CompletedA Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-HU6
Healthy
Phase 12024-03-26
WithdrawnPh 2a Study of HU6 on Energy Metabolism, Muscle and Liver Substrate Metabolism, and Mitochondrial Function in
Diabete Type 2, Obesity
Phase 22023-11-17
Active Not RecruitingPh 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis
Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, Fatty Liver
Phase 22023-09-05
CompletedExploratory Ph 2A, Double-Blind, Placebo-Controlled Dose Escalation Study of Safety, Tolerability, PD, & PK of
Heart Failure With Preserved Ejection Fraction
Phase 22022-10-30
CompletedSafety and Pharmacokinetics of HU6
Obese
Phase 12022-09-15
CompletedPhase 2a Study of HU6 in Subjects With Elevated Liver Fat and High BMI Volunteers
NASH - Nonalcoholic Steatohepatitis
Phase 22021-04-19
CompletedMultiple Ascending Dose Study of HU6 in High BMI Volunteers
NASH - Nonalcoholic Steatohepatitis
Phase 12021-01-04
CompletedAscending Dose Study of HU6 in Healthy Volunteers
NASH - Nonalcoholic Steatohepatitis
Phase 12020-08-12